EG
Everest Group, Ltd.
NYSEUSDEQUITY
Financial Services
DELAYED
Last price
370.06
▲ 1.70 (0.46%)
MARKET · —
Price
Open
368.36
Prev close
368.36
Day high
372.00
Day low
369.00
Volume
182.21K
Market cap
$14.19B
P/E (TTM)
7.82
52W range
302.44 – 401.07
Trailing performance
Returnvs SPY
1W
-0.01%
+1.4%
1M
-1.46%
-5.2%
3M
+3.82%
+0.7%
6M
+8.05%
-3.0%
YTD
+9.05%
-3.2%
1Y
+7.73%
-12.3%
3Y
+4.27%
-69.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$14.19B
Enterprise value$14.16B
Revenue (TTM)$16.82B
Gross profit$2.57B
EBITDA—
Net income$1.89B
EPS (TTM)$47.33
Free cash flow$2.06B
Total cash$3.62B
Total debt$3.59B
Book value / share$398.71
Shares outstanding38.34M
Float25.99M
Short % of float4.80%
Dividend yield2.16%
Beta (5Y)0.28
Valuation & profitability ratios
Trailing P/E7.82
Forward P/E6.19
PEG ratio0.97
Price / sales—
Price / book0.93
EV / revenue0.84
EV / EBITDA—
Gross margin15.28%
Operating margin19.13%
Profit margin11.38%
Return on equity12.57%
Return on assets2.49%
Debt / equity23.26
Current ratio0.39
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $15.51B | $15.81B | $14.73B | $12.34B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $1.59B | $1.37B | $2.52B | $597.00M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $1.59B | $1.37B | $2.52B | $597.00M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 14.53 | 14.85 | +2.2% |
| Mar 2026 | 13.96 | 16.08 | +15.2% |
| Dec 2025 | 13.83 | 13.26 | -4.1% |
| Sep 2025 | 14.52 | 7.54 | -48.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 8.20 | 13 | $3.05B | -18.6% |
| Next quarter | 13.40 | 13 | $3.13B | -19.9% |
| Current year | 53.77 | 14 | $12.40B | -20.0% |
| Next year | 59.75 | 14 | $12.09B | -2.6% |
Analyst targets & ownership
Mean target$408.47
High target$480.00
Low target$375.00
Implied upside10.38%
Analyst count15
ConsensusBUY
Strong buy / Buy3 / 3
Hold10
Sell / Strong sell0 / 0
Held by insiders0.83%
Held by institutions105.23%
Institutions holding1.01K
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
+55.54K
Net buying
Buy transactions
27
56.31K shares
Sell transactions
1
775 shares
Net transactions
+28
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
318.24K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 1, 26 | HOWARD JOHN M Director |
STOCK | 86 | $31.03K | Direct |
| Jul 1, 26 | LEVINE ALLAN Director |
STOCK | 86 | $31.03K | Direct |
| Jul 1, 26 | HARTZBAND MERYL D Director |
STOCK | 86 | $31.03K | Direct |
| May 12, 26 | HABAYEB ELIAS F Chief Financial Officer |
STOCK | 21.10K | $7.40M | Direct |
| May 7, 26 | KEEN JASON WARWICK Officer |
SELL | 775 | $272.68K | Direct |
| Apr 1, 26 | HOWARD JOHN M Director |
STOCK | 96 | $31.23K | Direct |
| Apr 1, 26 | PAGE ALAN DARRYL Director |
STOCK | 96 | $31.23K | Direct |
| Apr 1, 26 | LEVINE ALLAN Director |
STOCK | 96 | $31.23K | Direct |
| Apr 1, 26 | HARTZBAND MERYL D. Director |
STOCK | 96 | $31.23K | Direct |
| Mar 13, 26 | KOCIANCIC MARK Chief Financial Officer |
STOCK | 1.37K | $442.01K | Direct |
| Mar 13, 26 | WILLIAMSON JAMES ALLAN Chief Executive Officer |
STOCK | 1.13K | $364.52K | Direct |
| Mar 13, 26 | BEGGS JILL Officer |
STOCK | 684 | $220.84K | Direct |
| Feb 26, 26 | SINGER ROGER M Director |
STOCK | 960 | $325.14K | Direct |
| Feb 26, 26 | AMORE JOHN J Director |
STOCK | 960 | $325.14K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
AMORE JOHN J |
Director | 25.08K | Stock Award(Grant) |
GALTNEY WILLIAM F JR |
Director | 22.14K | Stock Award(Grant) |
GRAF JOHN A |
Director | 17.54K | Stock Award(Grant) |
HABAYEB ELIAS F |
Chief Financial Officer | 21.10K | Stock Award(Grant) |
KARMILOWICZ MICHAEL |
Officer | 12.73K | Sale |
KOCIANCIC MARK |
Chief Financial Officer | 35.09K | Stock Award(Grant) |
LOSQUADRO GERALDINE M |
Director | 13.24K | Stock Award(Grant) |
SINGER ROGER M |
Director | 19.70K | Stock Award(Grant) |
TARANTO JOSEPH V |
Director | 293.65K | Stock Award(Grant) |
WILLIAMSON JAMES ALLAN |
Chief Executive Officer | 29.64K | Stock Award(Grant) |
Moving averages & technicals
SMA 10
367.03
+0.83% from price
SMA 20
373.08
-0.81% from price
SMA 50
365.63
+1.21% from price
SMA 100
353.67
+4.63% from price
SMA 200
340.09
+8.81% from price
EMA 12
368.87
+0.32% from price
EMA 26
369.52
+0.15% from price
EMA 50
365.26
+1.31% from price
RSI (14)
50.6
Neutral
MACD (12,26,9)
-0.65
Hist -1.03
ATR (14)
7.07
1.91% of price
Realised vol 30D
25.6%
Annualised
Bollinger upper
392.10
20, 2σ
Bollinger lower
354.06
20, 2σ
50 / 200 cross
Golden
365.63 vs 340.09
Trend bias
Above 200
+8.81%
Risk profile
Beta vs SPY
-0.02
Less volatile than market
Correlation to SPY
-0.01
Largely independent
Realised vol 30D
25.6%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-16.4%
Peak to trough
Max drawdown 5Y
-26.5%
Peak to trough
ATR 14
7.07
1.91% of price
Beta (reported)
0.28
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.38
Call-heavy session
Put / call open interest
0.04
Positioning, not flow
Max pain
360.00
-2.7% from spot
ATM implied vol
23.9%
Nearest strike to spot
Skew (10% OTM)
-2.6%
Calls bid over puts
Call volume
16
Contracts, this expiry
Put volume
6
Contracts, this expiry
Heaviest call OI
380.00
729 contracts
Heaviest put OI
350.00
7 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
3 Insurance Stocks That Concern Us
StockStory · 1d ago
3 Reasons to Sell EG and 1 Stock to Buy Instead
StockStory · 3d ago
Kore.ai Named a Leader by Gartner, Forrester, and Everest Group Across Five Major Enterprise AI Evaluations
Business Wire · 3d ago
TD Cowen Adjusts Price Target on Everest to $385 From $365, Maintains Hold Rating
MT Newswires · 3d ago
IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group
Business Wire · 5d ago
Everest Group (EG) Files $300.7 Million Shelf Registration While Keeping Dividend In View
Simply Wall St. · 7d ago
Everest Group Lags Industry, Trades at a Discount: Time to Hold?
Zacks · 8d ago
AM Best Places Credit Ratings of Compañía de Seguros Generales Everest Mexico, S.A. de C.V. Under Review With Negative Implications
Business Wire · 9d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.